Somerset Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOMERSET THERAP
SOMERSET THERAP has eighty-one approved drugs.
Summary for Somerset Therap
| US Patents: | 0 |
| Tradenames: | 71 |
| Ingredients: | 70 |
| NDAs: | 81 |
| Patent Litigation for Somerset Therap: | See patent lawsuits for Somerset Therap |
Drugs and US Patents for Somerset Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Somerset Theraps Llc | BACLOFEN | baclofen | TABLET;ORAL | 090334-003 | Jan 31, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 218397-001 | Jun 7, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | RILPIVIRINE HYDROCHLORIDE | rilpivirine hydrochloride | TABLET;ORAL | 218798-001 | Jan 29, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | BEPOTASTINE BESILATE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 217770-001 | Aug 14, 2024 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | SODIUM ACETATE | sodium acetate | SOLUTION;INTRAVENOUS | 219826-002 | Sep 18, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

